"We do not yet know the price Gilead intends to charge for lenacapavir. Obviously, much of the world most impacted by HIV cannot afford U.S. pharmaceutical prices. I anticipate a fight to ensure true access for everyone. That's a fight I invite us all to join because, my god, we truly have the tools to end the scourge of HIV in our lifetime."